Delivery Order SPE2DB20D3103-SPE2DB23FN9V8
Award Date 7/13/23
Potential Completion Date 7/14/23
Potential Value $7.2K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,150.20 for 5,000 units of Thrombin-JMI vials on December 30, 2025, with completion scheduled for December 31, 2025. This firm fixed-price contract, which was competitively awarded without a set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Thrombin is a critical hemostatic agent used in surgical and medical applications to control...
- The Defense Logistics Agency awarded a $137,410 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20,000 unit vials of Thrombin-JMI. The prime contractor will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility to support Defense Logistics Agency procurement programs. No major subcontractors or set aside designations were identified. The delivery order was awarded against an existing DLA pharmaceutical supply vehicle and will provide needed...
- The Defense Logistics Agency awarded a $7,933.78 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Thrombin-JMI, a hemostatic agent used in surgical and medical applications. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of November 3, 2025. Performance will occur at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Thrombin-JMI 5,000 unit vials, with a ceiling value of $1,533.12. This is a firm fixed-price delivery order executed under a competitive, non-set-aside procurement. The contract is scheduled for ultimate completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,150.20 to AmerisourceBergen Drug Corp for 5,000 units of Thrombin-JMI vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on December 30, 2025, with an ultimate completion date of December 31, 2025. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Thrombin-JMI 5,000 unit vials. This competitively awarded, non-set-aside contract carries a ceiling value of $7,615.26 under a firm fixed-price delivery order arrangement, with an ultimate completion date of September 30, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Thrombin-JMI 5,000 Units Vials with a ceiling value of $1,451.48. This firm fixed price delivery order, which represents a child contract under a larger indefinite delivery vehicle, will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility and is scheduled for completion by November 28, 2025. The award was not designated as a set-aside contract,...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 15, 2025, for the supply of Thrombin-JMI 5,000 Units vials with a ceiling value of $1,188.00. This is a firm fixed-price delivery order issued under a competitive, non-set-aside procurement by the Medical Supply Chain, which operates under the Defense Logistics Agency within the Department of Defense. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Thrombin-JMI 5,000 Units Vials, a pharmaceutical product used in surgical hemostasis and wound management. This firm fixed-price delivery order has a ceiling value of $1,524.48 and an ultimate completion date of January 23, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Thrombin-JMI 5,000 Units Vials on April 23, 2025, with a ceiling value of $1,334.80. This competitively awarded, firm fixed price delivery order is scheduled for completion by April 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract involves no set-aside designation, reflecting AmerisourceBergen's capability to compete in open...